Evaluation of hepatic contrast enhancement with a hepatocyte-specific magnetic resonance imaging contrast agent (gadoxetic acid) in healthy dogs

• Alexandra ^[1] ; Stephanie ^[2] ; Thomas ^[3] ; Robert ^[4] ; Stephen ^[5]
  1. [1] K. Bratton
  2. [2] G. Nykamp
  3. [3] W. G. Gibson
  4. [4] Cruz-Arámbulo
  5. [5] A. Kruth

  Mostrar afiliaciones +
• Localización: American Journal of Veterinary Research, ISSN-e 1943-5681, ISSN 0002-9645, Vol. 76, Nº. 3, 2015, págs. 224-230
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Evaluation of hepatic contrast enhancement with a hepatocyte-specific magnetic resonance imaging contrast agent (gadoxetic acid) in healthy dogs Alexandra K. Bratton DVM; Stephanie G. Nykamp DVM; Thomas W. G. Gibson DVM, DVSc; Robert Cruz-Arámbulo DVM, MSc; Stephen A. Kruth DVM Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON, N1G 2W1, Canada. (Bratton, Nykamp, Gibson, Kruth); Antech Diagnostic Imaging Canada Ltd, 6625 Kitimat Rd, Mississauga, ON L5N 6J1, Canada. (Cruz-Arámbulo) Dr. Bratton's present address is Boundary Bay Veterinary Specialty Hospital, 306-6325 204th St, Langley, BC V2Y 3B3, Canada.

    Address correspondence to Dr. Bratton (abratton@bbvsh.com).

    OBJECTIVE To determine, by means of MRI, the time to maximal contrast enhancement in T1-weighted images following IV administration of gadoxetic acid in healthy dogs and assess the impact of gadoxetic acid on the signal intensity of T2-weighted images.

    ANIMALS 7 healthy dogs.

    PROCEDURES No hepatic abnormalities were detected during ultrasonographic examination. Each dog was anesthetized and positioned in dorsal recumbency for MRI. Transverse T1- and T2-weighted images of the liver were acquired prior to and following (at 5-minute intervals) IV injection of 0.1 mL of gadoxetic acid/kg. Signal intensity of the liver parenchyma was measured in 3 regions of interest in the T1- and T2-weighted images before and at various times point after contrast agent administration. Time versus signal-to-noise ratio curves were plotted to determine time to maximal contrast enhancement and contrast agent–related changes in signal intensity in T2-weighted images.

    RESULTS Analysis of T1-weighted images revealed that mean ± SD time to maximal enhancement after gadoxetic acid injection was 10.5 ± 3.99 minutes. Signal intensity of T2-weighted images was not significantly affected by gadoxetic acid administration. No injection-related adverse effects were observed in any dog.

    CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that gadoxetic acid can be used for hepatic MRI in healthy dogs and the resultant hepatic enhancement patterns are similar to those described for humans. Maximal contrast enhancement occurred between 10 and 15 minutes after contrast agent injection; thus, T2-weighted images may be obtained in the interval between injection and maximal enhancement for a more time-efficient clinical protocol.